Naloxone

Breastfeeding
  • TRADE NAMES: Evzio; Nalpin; Narcan; Narcanti; Narcotan; Suboxone (Reckitt Benckiser); Talwin-NX (Sanofi-Aventis); Targiniq (Purdue); Zynox
  • INDICATIONS: Narcotic overdose
  • CLASS: Opioid antagonist
  • HALF-LIFE: <1.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Thioridazine

PREGNANCY CATEGORY: C

Subuxone contains buprenorphine; Targiniq is naloxone and oxycodone.

Our database has 34 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
GENITOURINARY
OTHER


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of naloxone in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric